Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 22, 2026

Share-ify Unveils S.A.F.E. Score™, Introducing AI-Powered Supplier Risk Intelligence Across Its Food Safety and Compliance Portfolio
Catheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott’s Perclose Internal Vascular Closure Device
Full-Scenario Ecosystem, Measured Outcomes: Haier Biomedical Suzhou Builds Pharmacy Automation Brand Moat
P-Protect Patch Introduces P Protect Prostate Patch for Men’s Wellness Support
Abcourt Reports its Results for the Fourth Quarter and Year Ended June 30, 2026
Abcourt annonce ses résultats du quatrième trimestre et de l’exercice terminé le 30 juin 2026
CORRECTION -- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
VisCardia Announces Publication of RECOVER-HF Pilot Trial in JACC: Heart Failure
IBEX Limited to Announce First Quarter 2027 Financial Results on November 5, 2026
Forge Nano Lists on NASDAQ, Bringing Atomic-Scale Innovation to American Semiconductor and Battery Manufacturing
BlackLine Announces Date for Third Quarter 2026 Earnings Release and Conference Call
Turtle Beach Corporation to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Evaluating China Leading Fused Silica Rod Processor Contributions to Optical Innovation
Top Solar Panel Manufacturer Jingsun Expands Integrated Renewable Energy Solutions
SoundHound AI to Announce Third Quarter 2026 Financial Results on November 5th
BNB Standard Corporation Appoints Margaret Rosenfeld as Executive Vice President, Chief Strategy and Legal Officer
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.